38
Patent Ductus Arteriosus Dr. Arun George Paediatriic Emergency CMC Vellore

Patent ductus arteriosus

Embed Size (px)

Citation preview

Page 1: Patent ductus arteriosus

Patent Ductus ArteriosusDr. Arun GeorgePaediatriic EmergencyCMC Vellore

Page 2: Patent ductus arteriosus
Page 3: Patent ductus arteriosus
Page 4: Patent ductus arteriosus

Introduction Communication between the pulmonary

artery and the aorta Location – distal to left subclavian F:M = 2:1 Maternal rubella, prematurity

Page 5: Patent ductus arteriosus
Page 6: Patent ductus arteriosus
Page 7: Patent ductus arteriosus
Page 8: Patent ductus arteriosus

History: Irritable, feed poorly, fail to gain weight

and sweat excessively

Increased respiratory effort and respiratory rates

prone to develop recurrent upper respiratory infections and pneumonia

Page 9: Patent ductus arteriosus

Examination Physical underdevelopment

Wide pulse pressure – bounding peripheral pulses

Hyperkinetic apex, continuous thrill in 2nd lt ICS

Continous murmur

Page 10: Patent ductus arteriosus

Accentuated first sound and narrowly or paradoxically split second sound (large shunts)

Differential cyanosis and clubbing is pesent in shunt reversal

Page 11: Patent ductus arteriosus

What Physical Exam findings What Physical Exam findings are consistent with PDA?are consistent with PDA?

Murmur: systolic at LUSB/Left Infraclavicular, may progress to continuous (machinery)

Cardiac: Active Precordium, Widened Pulse Pressure, Bounding Pulses

Respiratory Sx: Tachypnea, Apnea

Page 12: Patent ductus arteriosus

Hemodynamics Flow during both systole and diastole –

pressure gradient present throughout (pulm artery pressure normal)

Continuous murmur Overload of pulm artery increased

flow through left atrium and ventricle – accentuated first sound and mitral delayed diastolic murmur

Delayed closure of aortic valve & late A2 (S2 may be paradoxically split)

Page 13: Patent ductus arteriosus

Dilatation of the ascending aorta Aortic ejection click – preceeding the

conti nuous murmur Aortic ejection systolic murmur –

drowned by the loud continuous murmur

Page 14: Patent ductus arteriosus
Page 15: Patent ductus arteriosus
Page 16: Patent ductus arteriosus

ECG

Page 17: Patent ductus arteriosus

CXR

Page 18: Patent ductus arteriosus

Echocardiogram Gold standard for diagnosing PDA

Taken from Neo Reviews

Page 19: Patent ductus arteriosus

Color and pulsed doppler Cardiac catheterisation

Page 20: Patent ductus arteriosus

Assessment of severity Heart size Third sound and diastolic murmur Pulse pressure

Page 21: Patent ductus arteriosus

Course and Complications Ejection systolic murmur at birth (due to

pulmonary hypertension) continuous murmur after a few weeks

Development of Pulmonary arterial hypertension diastolic component lost ejection systolic murmur

Severe PAH rt to lft shunt disappearance of the murmur and appearance of differential cyanosis

Page 22: Patent ductus arteriosus

Complications: Cardiac failure Infective endarteritis Eisenmenger

Rare complications -aneurysmal dilatation of the pulmonary artery or the ductus-calcification of the ductus-noninfective thrombosis of the ductus with embolization-paradoxical emboli

Page 23: Patent ductus arteriosus

DDXAorticopulmonary window defectRuptured sinus of valsalva aneurysmCoronary arteriovenous fistulasAberrant left coronary with massive

collaterals from the rightTruncus arteriosusVSD with aortic insufficiencyPeripheral pulmonic stenosisVenous hum in TAPVC

Page 24: Patent ductus arteriosus

TreatmentPremature Indomethacin

0.1mg/kg/dose 12 hourly 3 doses

Page 25: Patent ductus arteriosus

Prophylactic indomethacin has short-term benefits for preterm infants including a reduction in the incidence of symptomatic PDA, PDA surgical ligation, and severe intraventricular haemorrhage. However, there is no evidence of effect on mortality or neurodevelopment.

Cochrane review 2010: Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants Peter W Fowlie et al

Page 26: Patent ductus arteriosus

Ibuprofen is as effective as indomethacin in closing a PDA and currently appears to be the drug of choice. Ibuprofen reduces the risk of NEC and transient renal insufficiency. 

Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants Cochrane reviews 2015- Arne Ohlsson, Rajneesh Walia, Sachin S Shah

Page 27: Patent ductus arteriosus

Paracetamol appears to be a promising new alternative to indomethacin and ibuprofen for the closure of a PDA with possibly fewer adverse effects.

Paracetamol (acetaminophen) for patent ductus arteriosus in preterm and low-birth-weight infants Cochrane review March 2015- Ohlsson A, Shah PS

Page 28: Patent ductus arteriosus

Treatment All patients with PDA require surgical or

catheter closure.

Rationale: Small PDA- prevention of bacterial endarteritis

Moderate to large PDA- to treat heart failure or prevent the development of pulmonary vascular disease, or both.

Page 29: Patent ductus arteriosus

Cardiac catheterization – Trans catheter closure Small PDAs- closed with intravascular

coils.

Moderate to large – catheter introduced sacs or umbrella like device

Page 30: Patent ductus arteriosus

Intravascular coils - gianturco

Page 31: Patent ductus arteriosus
Page 32: Patent ductus arteriosus

Amplatzer patch

Page 33: Patent ductus arteriosus
Page 34: Patent ductus arteriosus

Surgery Left thoracotomy

Thoracoscopic minimally invasive techniques.

Page 35: Patent ductus arteriosus
Page 36: Patent ductus arteriosus

Closure of the ductus is indicated even in asymptomatic patients, preferably before 1 year of age.

Page 37: Patent ductus arteriosus

Reference: Nelson’s textbook of Paediatrics 20e Ghai Essential Paediatrics 8e Uptodate.com Medscape Wikipedia Cochrane reviews

Page 38: Patent ductus arteriosus